Clinical Trials Logo

Clinical Trial Summary

To assess, under daily practice conditions, the safety profile and the efficacy of a new formulation of alfuzosin administered once daily (Xatral XL) in patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00575913
Study type Interventional
Source Sanofi
Contact
Status Completed
Phase Phase 4
Start date September 2003
Completion date March 2005

See also
  Status Clinical Trial Phase
Completed NCT00941343 - Benign Prostatic Hyperplasia in Taiwan N/A
Completed NCT02074644 - Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia N/A
Active, not recruiting NCT03344757 - Health Gatherings - For Your Health After Cancer N/A
Terminated NCT02606123 - Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer Phase 1/Phase 2
Not yet recruiting NCT02245334 - A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy Phase 4
Active, not recruiting NCT01464216 - MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Not yet recruiting NCT05574647 - Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer N/A
Completed NCT03192917 - Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy N/A
Recruiting NCT03711643 - Hypnosis Mask: a New Approach to Management of Pain in Medical Imaging N/A
Completed NCT03104907 - Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer N/A
Completed NCT03099421 - Prostatic Artery Embolization for Benign Prostatic Obstruction N/A
Completed NCT00853710 - Test Semiquantitative Prostate Specific Antigen (PSA) N/A
Completed NCT01316458 - Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy Phase 2
Recruiting NCT05413850 - Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection Phase 1/Phase 2
Completed NCT05941260 - Standardization of Prostatic Resection by Virtual Computational Reconstruction and Computational Flow Dynamics
Terminated NCT02031029 - Character Traits and Stress in Suspected Prostate Cancer N/A
Completed NCT00484783 - Transluminal Flexible Endoscopic Procedure in Foregut and Urologic Surgery N/A
Terminated NCT00672009 - A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer Phase 2
Approved for marketing NCT04452136 - Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer